Cargando…
A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
BACKGROUND: Constitutive activation of nuclear factor κB (NF-κB) is a hallmark of activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL). Mutations in the A20 gene activate NF-κB, but the prognostic value of A20 mutations in ABC-DLBLC is unclear. PURPOSE: To investigate the prognostic value...
Autores principales: | Cen, Hong, Tan, Xiaohong, Guo, Baoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696786/ https://www.ncbi.nlm.nih.gov/pubmed/26716984 http://dx.doi.org/10.1371/journal.pone.0145037 |
Ejemplares similares
-
SGK1 mutation status can further stratify patients with germinal center B‐cell‐like diffuse large B‐cell lymphoma into different prognostic subgroups
por: Guo, Baoping, et al.
Publicado: (2022) -
Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma
por: Cao, Baoping, et al.
Publicado: (2021) -
MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma
por: Kwanhian, Wiyada, et al.
Publicado: (2012) -
Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma
por: Kim, Eugene, et al.
Publicado: (2022) -
Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas
por: Tzankov, Alexandar, et al.
Publicado: (2007)